Bli medlem
Bli medlem

Du är här

2015-04-13

Orion Oyj: Invitation to Orion's Capital Markets Day on 26 May 2015

Orion Corporation has the pleasure to invite analysts, institutional investors
and media to its Capital Markets Day 2015 on Tuesday, 26 May 2015. The event
will be held at Finlandia Hall, Mannerheimintie 13, Helsinki (Veranda, ground
floor).

Preliminary agenda (subject to change)
------------------------------------------------------------------------------
| 8.15 Registration and breakfast |
| 8.55 Opening remarks |
| |
| |
| Tuukka Hirvonen,Communications Manager - IR&Financial Communications |
| 9.00 CEO's presentation |
| |
| |
| Timo Lappalainen,President&CEO |
| R&D pipeline review, part I |
| |
| |
| Reijo Salonen,SVP Research&Development |
| 10.00 Break |
| 10.15 Proprietary Products update |
| |
| |
| Markku Huhta-Koivisto,SVP Proprietary Products |
| Specialty Products update |
| |
| |
| Liisa Hurme,SVP Specialty Products |
| CFO's presentation |
| |
| |
| Jari Karlson,CFO |
| 11.35 Break |
| 11.45 Animal Health |
| |
| |
| Niclas Lindstedt, Vice President |
| Fermion |
| |
| |
| Arto Toivonen, President |
| Orion Diagnostica |
| |
| |
| Jaakko Rissanen, President |
| R&D pipeline review, part II |
| |
| |
| Reijo Salonen,SVP Research&Development |
| 13.00 Lunch and discussion with management |
| 14.30 Event ends |
------------------------------------------------------------------------------
The presentations can also be followed through live webcast
atwww.orion.fi/en/investors. The presentation materials will be available on
Orion website during the day and recordings of the presentations latest on
the following day.

Please register to the event by email:ir@orion.fior by tel. +358 10 426 2169 /
+358 10 426 2721no later than on Friday 15 May 2015 at 3.00 p.m. EEST.

Participants should be prepared to present a photo ID on request.

We hope you and your colleagues will take the opportunity to participate, and
we look forward to meeting you there.

Yours sincerely,

Timo Lappalainen
President and CEO

Travel and accommodation

In order to assist you, we have reserved a quota of hotel rooms at Hotel
Scandic Park which is a short walking distance from the venue Finlandia Hall.
The rate for single room is EUR 134 and for double room EUR 154 (check in on
May 25, check out May 26). Please refer to booking referenceORI250515
when making your reservation.

Scandic Park Helsinki, Mannerheimintie 46
Tel: +358 9 47 371
E-mail: parkhelsinki@scandichotels.com
http://www.scandichotels.com/

Participants are kindly asked to book their own flights and arrange
transportation from and to the airport. Please note that Orion does not cover
any costs for travelling or accommodation.

For further information, please contact:

Tuukka Hirvonen,Communications Manager
, tel. +358 10 426 2721 ortuukka.hirvonen@orion.fi

Publisher:

Orion Corporation
www.orion.fi/en
www.orion.fi/en/investors
Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical
ingredients and diagnostic tests. The company is continuously developing new
drugs and treatment methods. The core therapy areas of Orion's pharmaceutical
R&D are central nervous system (CNS) disorders, oncology and respiratory for
which Orion developes inhaled Easyhaler® pulmonary drugs.

Orion's net sales in 2014 amounted to EUR 1,015 million and the company had
about 3,500 employees. Orion's A and B shares are listed on NASDAQ Helsinki.

Invitation Orion CMD 2015
http://hugin.info/3079/R/1910509/681380.pdf

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Orion Oyj via Globenewswire

HUG#1910509

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.